Katariina Sivenius
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Physiology top 10%
- Adipose Tissue and Metabolism
- Diet and metabolism studies
Papers in
-
- Adipose Tissue and Metabolism 5
- Diet and metabolism studies 1
-
- Aldose Reductase and Taurine 2
- Co-authors
- Matti I.J. Uusitupa (9 shared papers)Markku Laakso (7 shared papers)LEO K. NISKANEN (8 shared papers)Raisa Valve (2 shared papers)Jussi Pihlajamäki (2 shared papers)Raija Miettinen (1 shared paper)A Rissanen (1 shared paper)S S Deeb (1 shared paper)
- Journals
- International Journal of Obesity (3 papers)Diabetologia (1 paper)BMJ Open (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Diabetic Medicine (1 paper)
- Partner nations
- FinlandFranceSwitzerland
In The Last Decade
Katariina Sivenius
13 papers receiving 943 citations
Katariina Sivenius's Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 202
- Physiology 251
- Neurology 87
- Hepatology 40
- Endocrine and Autonomic Systems 32
Countries citing papers authored by Katariina Sivenius
This map shows the geographic impact of Katariina Sivenius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katariina Sivenius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katariina Sivenius more than expected).
Fields of papers citing papers by Katariina Sivenius
This network shows the impact of papers produced by Katariina Sivenius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katariina Sivenius. The network helps show where Katariina Sivenius may publish in the future.
Co-authors
The 25 scholars most cited alongside Katariina Sivenius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 289 |
| 2 | 1999 | 195 | |
| 3 | 2007 | 102 | |
| 4 | 2007 | 74 | |
| 5 | 1999 | 70 | |
| 6 | 2022 | 43 | |
| 7 | 2001 | 39 | |
| 8 | 2000 | 39 | |
| 9 | 2004 | 36 | |
| 10 | 2004 | 32 | |
| 11 | 2003 | 27 | |
| 12 | 2022 | 20 | |
| 13 | 2003 | 11 |
About Katariina Sivenius
Katariina Sivenius is a scholar working on Physiology, Cell Biology, Critical Care and Intensive Care Medicine, Endocrine and Autonomic Systems and Biochemistry, having authored 13 papers that have together received 977 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (5 papers), Aldose Reductase and Taurine (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Diet and metabolism studies (1 paper), Lipid metabolism and biosynthesis (1 paper), COVID-19 Clinical Research Studies (1 paper), Respiratory viral infections research (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Infectious Diseases (202 citations), Physiology (251 citations), Neurology (87 citations), Hepatology (40 citations) and Endocrine and Autonomic Systems (32 citations). Katariina Sivenius has collaborated with scholars based in Finland, France and Switzerland. Frequent co-authors include Matti I.J. Uusitupa, Markku Laakso, LEO K. NISKANEN, Raisa Valve, Jussi Pihlajamäki, Raija Miettinen, A Rissanen, S S Deeb, Johan H. Auwerx and Virpi Lindi. Their work appears in journals such as International Journal of Obesity, Diabetologia, BMJ Open, The Journal of Clinical Endocrinology & Metabolism and Diabetic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.